The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.
By Thomas Kaplan, Sheryl Gay Stolberg and Rebecca Robbins
Published May 5, 2021 Updated May 6, 2021, 5:14 a.m. ET
WASHINGTON — The Biden administration came out on Wednesday in support of waiving intellectual property protections for coronavirus vaccines, siding with international efforts to bolster production amid concerns about vaccine access in developing nations.
Read the full article in the New York Times